SARS-CoV-2 mRNA Vaccines: Immunological Mechanism and Beyond
Top Cited Papers
Open Access
- 12 February 2021
- Vol. 9 (2), 147
- https://doi.org/10.3390/vaccines9020147
Abstract
To successfully protect against pathogen infection, a vaccine must elicit efficient adaptive immunity, including B and T cell responses. While B cell responses are key, as they can mediate antibody-dependent protection, T cells can modulate B cell activity and directly contribute to the elimination of pathogen-infected cells. In the unprecedented race to develop an effective vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of the respiratory disease coronavirus disease 2019 (COVID-19), messenger RNA (mRNA) vaccines have emerged as front runners thanks to their capacity for rapid development and ability to drive potent adaptive immune responses. In this review article, we provide an overview of the results from pre-clinical studies in animal models as well as clinical studies in humans that assessed the efficacy of SARS-CoV-2 mRNA vaccines, with a primary focus on adaptive immune responses post vaccination.Keywords
Funding Information
- NIH NIAID (R01 AI123738 and R01 AI153064)
This publication has 84 references indexed in Scilit:
- Biodegradable Lipids Enabling Rapidly Eliminated Lipid Nanoparticles for Systemic Delivery of RNAi TherapeuticsMolecular Therapy, 2013
- A Double-Inactivated Severe Acute Respiratory Syndrome Coronavirus Vaccine Provides Incomplete Protection in Mice and Induces Increased Eosinophilic Proinflammatory Pulmonary Response upon ChallengeJournal of Virology, 2011
- Immunosenescence: Implications for vaccination programmes in adultsMaturitas, 2011
- From Vaccines to Memory and BackImmunity, 2010
- Correlates of Protection Induced by VaccinationClinical and Vaccine Immunology, 2010
- Cytokine-secreting follicular T cells shape the antibody repertoireNature Immunology, 2009
- Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological StabilityMolecular Therapy, 2008
- Duration of Humoral Immunity to Common Viral and Vaccine AntigensThe New England Journal of Medicine, 2007
- Regulation of antibody isotype secretion by subsets of antigen-specific helper T cellsNature, 1988
- Interferon-γ and B Cell Stimulatory Factor-1 Reciprocally Regulate Ig Isotype ProductionScience, 1987